{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:41:17Z","timestamp":1778791277086,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000087","name":"Dalhousie University Faculty of Graduate Studies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020170","name":"Research Nova Scotia","doi-asserted-by":"publisher","award":["2021-1721"],"award-info":[{"award-number":["2021-1721"]}],"id":[{"id":"10.13039\/501100020170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.psychres.2022.114891","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T21:24:58Z","timestamp":1665177898000},"page":"114891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Genetic factors contribute to medication-induced QT prolongation: A review"],"prefix":"10.1016","volume":"317","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6047-0766","authenticated-orcid":false,"given":"Temi","family":"Toba-Oluboka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Tibbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9544-3944","authenticated-orcid":false,"given":"Martin","family":"Alda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.psychres.2022.114891_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/tpj.2010.76","article-title":"Genome-wide association study of antipsychotic-induced QTc interval prolongation","volume":"12","author":"\u00c5berg","year":"2012","journal-title":"Pharmacogenom. J."},{"issue":"16","key":"10.1016\/j.psychres.2022.114891_bib0002","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.289.16.2120","article-title":"What clinicians should know about the QT interval","volume":"289","author":"Al-Khatib","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.psychres.2022.114891_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psym.2012.11.001","article-title":"QTc prolongation, torsades de pointes, and psychotropic medications","volume":"54","author":"Beach","year":"2013","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.psychres.2022.114891_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2017.10.009","article-title":"QT Prolongation, torsades de pointes, and psychotropic medications: a 5-year update","volume":"59","author":"Beach","year":"2018","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.psychres.2022.114891_bib0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.annemergmed.2014.12.005","article-title":"Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram","volume":"66","author":"Berling","year":"2015","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.psychres.2022.114891_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112851","article-title":"EPB41L4A and LEP gene polymorphisms are associated with antipsychotic-induced QTc interval prolongation in Han Chinese","volume":"286","author":"Cao","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114891_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f288","article-title":"QT interval and antidepressant use: a cross sectional study of electronic health records","volume":"346","author":"Castro","year":"2013","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.psychres.2022.114891_bib0008","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hup.540","article-title":"Prolonged QTc intervals in medicated patients with schizophrenia","volume":"18","author":"Chong","year":"2003","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114891_bib0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000493400","article-title":"Corrected QT interval prolongation in psychopharmacological treatment and its modulation by genetic variation","volume":"77","author":"Corponi","year":"2019","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.psychres.2022.114891_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/039463201102400127","article-title":"The use of first generation versus second generation antipsychotics as add-on or as switch treatment and its effect on QTc interval: the Italian experience in a real-world setting","volume":"24","author":"Di Sciascio","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114891_bib0011","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcpt.12720","article-title":"Electrocardiogram alterations associated with psychotropic drug use and CACNA1C gene variants in three independent samples","volume":"120","author":"Fabbri","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.psychres.2022.114891_bib0012","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr. Probl. Cardiol."},{"issue":"11","key":"10.1016\/j.psychres.2022.114891_bib0013","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"7372","key":"10.1016\/j.psychres.2022.114891_bib0014","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","article-title":"Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data","volume":"325","author":"Hennessy","year":"2002","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.psychres.2022.114891_bib0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/02698811211003477","article-title":"Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age","volume":"35","author":"Hommers","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.psychres.2022.114891_bib0016","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/1060028014550645","article-title":"Risk of QT\/QTc prolongation among newer non-SSRI antidepressants","volume":"48","author":"Jasiak","year":"2014","journal-title":"Ann. Pharmacother."},{"issue":"11","key":"10.1016\/j.psychres.2022.114891_bib0017","first-page":"546","article-title":"Thioridazine hydrochloride (mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities","volume":"89","author":"Kelly","year":"1963","journal-title":"Can. Med. Assoc. J."},{"issue":"4","key":"10.1016\/j.psychres.2022.114891_bib0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YIC.0000000000000124","article-title":"A thorough QT study to evaluate the QTc prolongation potential of two neuropsychiatric drugs, quetiapine and escitalopram, in healthy volunteers","volume":"31","author":"Kim","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"9896","key":"10.1016\/j.psychres.2022.114891_bib0019","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet North Am. Ed."},{"issue":"1","key":"10.1016\/j.psychres.2022.114891_bib0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41398-022-01825-0","article-title":"ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study","volume":"12","author":"Lu","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114891_bib0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: Mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.psychres.2022.114891_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00109-003-0522-z","article-title":"Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients","volume":"82","author":"Paulussen","year":"2004","journal-title":"J. Mol. Med."},{"issue":"6","key":"10.1016\/j.psychres.2022.114891_bib0023","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pds.1746","article-title":"Drug-induced torsades de pointes: data mining of the public version of the FDA adverse event reporting system (AERS)","volume":"18","author":"Poluzzi","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"1","key":"10.1016\/j.psychres.2022.114891_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e31827c0314","article-title":"A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and\/or CYP3A4 and a comparison to quetiapine and ziprasidone","volume":"33","author":"Potkin","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"9209","key":"10.1016\/j.psychres.2022.114891_bib0025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet N. Am. Ed."},{"issue":"2","key":"10.1016\/j.psychres.2022.114891_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMcp0706513","article-title":"Long-QT Syndrome","volume":"358","author":"Roden","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.psychres.2022.114891_bib0027","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.psychres.2022.114891_bib0028","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.116.023980","article-title":"Common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk","volume":"135","author":"Strauss","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.psychres.2022.114891_bib0029","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/tpj.2014.6","article-title":"Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia","volume":"14","author":"Suzuki","year":"2014","journal-title":"Pharmacogenom. J."},{"issue":"1","key":"10.1016\/j.psychres.2022.114891_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2125.2010.03660.x","article-title":"Drug- and non-drug-associated QT interval prolongation","volume":"70","author":"van Noord","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114891_bib0031","first-page":"205","article-title":"New Generation antipsychotic drugs and qtc interval prolongation","volume":"5","author":"Vieweg","year":"2003","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114891_bib0032","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0447.2005.00592.x","article-title":"Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine","volume":"112","author":"Vieweg","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"issue":"11","key":"10.1016\/j.psychres.2022.114891_bib0033","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/mp.2008.52","article-title":"Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia","volume":"14","author":"Volpi","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114891_bib0034","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/JCP.0000000000000724","article-title":"Effect of GWAS-identified genetic variants on maximum QT interval in patients with schizophrenia receiving antipsychotic agents: a 24-hour holter ECG study","volume":"37","author":"Watanabe","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"14","key":"10.1016\/j.psychres.2022.114891_bib0035","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jacc.2014.01.031","article-title":"Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long qt interval syndrome","volume":"63","author":"Weeke","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"41","key":"10.1016\/j.psychres.2022.114891_bib0036","first-page":"687","article-title":"QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes","volume":"108","author":"Wenzel-Seifert","year":"2011","journal-title":"Dtsch. Arztebl. Int."},{"issue":"6","key":"10.1016\/j.psychres.2022.114891_bib0037","first-page":"523","article-title":"Drug induced QT prolongation","volume":"14","author":"Zar\u0119ba","year":"2007","journal-title":"Cardiol J."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:03:24Z","timestamp":1759039404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122004838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":37,"alternative-id":["S0165178122004838"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114891","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic factors contribute to medication-induced QT prolongation: A review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114891"}}